6 days ago5 min read
350
Inno4Vac is a public-private partnership that addresses scientific bottlenecks in vaccine development.
It proposes to develop predictive biological and mathematical models of vaccine performance and bio-manufacturing.
Artificial intelligence combined with big data and computational modelling will be used to build an open-access and cloud-based platform for in silico vaccine efficacy assessment and development. Controlled human infection models and cell-based human in vitro 3D models will be developed to enable early evaluation of vaccine efficacy and prediction of immune protection.
Finally, for vaccine bio-manufacturing the goal is to establish an open source in silico simulation platform for guiding the production of vaccine candidates and associated stability testing.
innovations to accelerate vaccine development and manufacture